↓ Skip to main content

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target

Overview of attention for article published in Frontiers in oncology, April 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
Published in
Frontiers in oncology, April 2021
DOI 10.3389/fonc.2021.629846
Pubmed ID
Authors

Xiaofeng Duan, Stephen Iwanowycz, Soo Ngoi, Megan Hill, Qiang Zhao, Bei Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 7 12%
Student > Ph. D. Student 6 10%
Student > Doctoral Student 5 8%
Student > Bachelor 5 8%
Researcher 4 7%
Other 5 8%
Unknown 27 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 20%
Unspecified 7 12%
Medicine and Dentistry 4 7%
Nursing and Health Professions 2 3%
Veterinary Science and Veterinary Medicine 1 2%
Other 4 7%
Unknown 29 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2023.
All research outputs
#8,147,875
of 26,163,973 outputs
Outputs from Frontiers in oncology
#2,930
of 22,913 outputs
Outputs of similar age
#170,815
of 460,125 outputs
Outputs of similar age from Frontiers in oncology
#169
of 1,180 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,125 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 1,180 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.